This medication is prescribed for the treatment of ovarian cancer. It contains platinum; stops the growth of cancer cells.
Contraindicated to patients with history of known hypersensitivity, severe blood disorders (bone marrow depression, significant bleeding), during pregnancy and lactation. Aluminum tends to inavtivate carboplatin, hence the infusion sets or needles used to administer carboplatin should not contain aluminum
The recommended dose is 360 mg/m2 when given as a single IV drug and . 300 mg/m2 with cyclophosphamide. It should be given as one dose every 4 weeks. If needed adjust the dosage depends upon white blood cells and platelet counts.
This medication available in the form of injection administered by healthcare providers.
Give information to your doctor about platinum compound intakes.
Harmful to new born babies. It may cause diminished kidney function; affects nervous system; liver function impairment.
Caution needed while using in elderly patients, and during breastfeeding.
Loss of appetite, stomach pain, diarrhea, constipation, nausea and vomiting, mouth blistering.
Skin: Thinned or brittle hair.
Central Nervous System: Fatigue, dizziness.
Miscellaneous: Red urine, black or tarry tools, fever, chills, shortness of breath, swelling of ankles, abnormal sounds from outside.
Avoid vaccination while taking this medication.
Intravenous: Store at 25°C.
Subscribe to our Free Newsletters!